Possible Role of Interleukin-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity

Imatinib mesylate is a small-molecule tyrosine kinase inhibitor (TKi) designed to target c-ABL and BCR-ABL, approved for the treatment of chronic myeloid leukemia and gastrointestinal stromal tumors. Adverse cutaneous reactions induced by imatinib are frequent, generally moderate, and dose-dependent...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Turk J Haematol
Autors principals: Musolino, Caterina, Allegra, Alessandro, Mannucci, Carmen, Russo, Sabina, Alonci, Andrea, Maisano, Valerio, Calapai, Gioacchino, Gangemi, Sebastiano
Format: Artigo
Idioma:Inglês
Publicat: Galenos Publishing 2015
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4451486/
https://ncbi.nlm.nih.gov/pubmed/26316486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjh.2014.0021
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars